David Tepper’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

David Tepper’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-425,000	Closed	-$33.7M	–	60
2017 Q2	$33.7M	Buy	+425,000	New	+$32.4M	0.5%	41

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

SGI

Swan Global Investments Durango, Colorado $3.39B AUM 20.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

David Tepper's XLV Position: Q3 2017 in Review

David Tepper sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2017, closing a stake of 425,000 shares — an estimated $33.7M sold.

David Tepper first reported a position in XLV in Q2 2017 and held it in 1 quarter. The position peaked at $33.7M in Q2 2017. 704 funds tracked by Wall St. Rank hold XLV as of Q3 2017.

David Tepper reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2017 after selling out during the quarter.
David Tepper sold 425,000 State Street Health Care Select Sector SPDR ETF shares in Q3 2017, an estimated $33.7M.
David Tepper first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2017 and held it in 1 quarter.
David Tepper's State Street Health Care Select Sector SPDR ETF position peaked at $33.7M in Q2 2017.
704 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2017.

Based on Appaloosa LP's 13F filing for Q3 2017, filed 14 Nov 2017.